These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 8797113
21. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM. Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934 [Abstract] [Full Text] [Related]
22. Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. Barone LM, Owen TA, Tassinari MS, Bortell R, Stein GS, Lian JB. J Cell Biochem; 1991 Aug; 46(4):351-65. PubMed ID: 1757478 [Abstract] [Full Text] [Related]
23. Collagen glycation alters neovascularization in vitro and in vivo. Francis-Sedlak ME, Moya ML, Huang JJ, Lucas SA, Chandrasekharan N, Larson JC, Cheng MH, Brey EM. Microvasc Res; 2010 Jul; 80(1):3-9. PubMed ID: 20053366 [Abstract] [Full Text] [Related]
24. Bone loss in experimental diabetes. Comparison with the model of inflammation mediated osteopenia. Hadjidakis D, Lempert UG, Minne HW, Ziegler R. Horm Metab Res; 1993 Feb; 25(2):77-81. PubMed ID: 8458612 [Abstract] [Full Text] [Related]
25. Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats. Tomasek JJ, Meyers SW, Basinger JB, Green DT, Shew RL. Life Sci; 1994 Feb; 55(11):855-61. PubMed ID: 8072386 [Abstract] [Full Text] [Related]
26. Rat tissue collagen modified by advanced glycation: correlation with duration of diabetes and glycemic control. Turk Z, Misur I, Turk N, Benko B. Clin Chem Lab Med; 1999 Aug; 37(8):813-20. PubMed ID: 10536930 [Abstract] [Full Text] [Related]
27. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE. J Clin Invest; 1997 Mar 01; 99(5):1016-27. PubMed ID: 9062360 [Abstract] [Full Text] [Related]
28. Type VI collagen deficiency induces osteopenia with distortion of osteoblastic cell morphology. Izu Y, Ezura Y, Mizoguchi F, Kawamata A, Nakamoto T, Nakashima K, Hayata T, Hemmi H, Bonaldo P, Noda M. Tissue Cell; 2012 Feb 01; 44(1):1-6. PubMed ID: 22071216 [Abstract] [Full Text] [Related]
29. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Romero DF, Bryer HP, Rucinski B, Isserow JA, Buchinsky FJ, Cvetkovic M, Liu CC, Epstein S. Calcif Tissue Int; 1995 Jan 01; 56(1):54-61. PubMed ID: 7796348 [Abstract] [Full Text] [Related]
30. Age-associated changes of extracellular matrix collagen impair lung cancer cell migration. Bartling B, Desole M, Rohrbach S, Silber RE, Simm A. FASEB J; 2009 May 01; 23(5):1510-20. PubMed ID: 19109409 [Abstract] [Full Text] [Related]
31. Osteopenia: a bone disorder associated with diabetes mellitus. Duarte VM, Ramos AM, Rezende LA, Macedo UB, Brandão-Neto J, Almeida MG, Rezende AA. J Bone Miner Metab; 2005 May 01; 23(1):58-68. PubMed ID: 15616896 [Abstract] [Full Text] [Related]
34. Nonenzymatic glycosylation of vitreous proteins in vitro and in the streptozotocin-treated diabetic rat. Shires TK, Faeth JA, Pulido JS. Retina; 1990 May 01; 10(2):153-8. PubMed ID: 2144905 [Abstract] [Full Text] [Related]
35. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin-induced diabetes. Ishida H, Seino Y, Takeshita N, Kurose T, Tsuji K, Okamoto Y, Someya Y, Hara K, Akiyama Y, Imura H. Acta Endocrinol (Copenh); 1992 Jul 01; 127(1):81-5. PubMed ID: 1387756 [Abstract] [Full Text] [Related]
37. Tetracyclines inhibit protein glycation in experimental diabetes. Ryan ME, Ramamurthy NS, Golub LM. Adv Dent Res; 1998 Nov 01; 12(2):152-8. PubMed ID: 9972141 [Abstract] [Full Text] [Related]
38. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, Pischon N, Trackman PC, Gerstenfeld L, Graves DT. Bone; 2007 Feb 01; 40(2):345-53. PubMed ID: 17064973 [Abstract] [Full Text] [Related]
39. Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy. Aoki C, Uto K, Honda K, Kato Y, Oda H. Lab Invest; 2013 Nov 01; 93(11):1170-83. PubMed ID: 23979426 [Abstract] [Full Text] [Related]